Press release
Anti-Malarial Drug Market Statistics by 2023 Leading Players GlaxoSmithKline, Ranbaxy, Zydus Cadila, Pfizer, Novartis
Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/2760?utm_source=openpr_ss
The global malaria epidemic has soared, and the global anti-malarial market is evolving. Favorable government regulations, multi-drug resistance (MDR) development, research, development and innovation in anti-malarial drugs are expected to complement market growth. However, side effects of antimalarial agents such as anxiety and dizziness insomnia interfere with the growth of this market.
The global anti-malarial drug market is divided on the basis of drug types, malaria types, mechanisms of action, distribution channels and geography. Depending on the drug type, it is divided into quinine, chloroquine, pyrimethamine, amodiaquine, proguanil, mefloquine, sulfonamide, artemisinin and derivatives, atovaquone, primaquine, halofantrine, doxycycline and clindamycin.
In the case of the malaria type, it is classified as plasmodium falciparum, plasmodium vivax, plasmodium malariae and plasmodium ovale. It is divided into two categories as resistance and prevention by the behavioral mechanism. In addition, through the channels of distribution, anti-malarial drugs market is divided into hospital pharmacy, retail pharmacy, electronic commerce.
Get Purchase Enquiry On this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/2760?utm_source=openpr_ss
Market Players:
• GlaxoSmithKline Plc
• Ranbaxy Laboratories
• Zydus Cadila
• Alvizia Health Care
• Bayer AG
• Pfizer Inc.
• Ipca Laboratories Ltd
• Merck KGaA
Key Benefits of Report:
• The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2017 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
• Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
• Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
• Extensive analysis by product elucidates the use of anti-malarial drugs in medical settings.
Browse More Details of Report @ https://www.alliedmarketresearch.com/anti-malarial-drug-market?utm_source=openpr_ss
About Us:
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-Malarial Drug Market Statistics by 2023 Leading Players GlaxoSmithKline, Ranbaxy, Zydus Cadila, Pfizer, Novartis here
News-ID: 1561883 • Views: …
More Releases from Allied Market Research
Service Robotics Market to Reach $293.0 Billion, Globally, by 2032 at 24.3% CAGR …
Allied Market Research published a report, titled, "Service Robotics Market by Type (Professional Service Robotics, and Personal Service Robotics), and Application (Agriculture, Professional Cleaning, Inspection and Maintenance, Construction and Demolition, Transportation and Logistics, Medical, Search, Rescue, And Security, Hospitality, and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032.". According to the report, the global service robotics industry generated $21.0 billion in 2020, and is anticipated to generate $293.0 billion by…
Waste Management Industry to Surpass $3.5 Trillion by 2032, Growing at a Robust …
Allied Market Research published a report titled, "Waste Management Market by Type (Municipal Waste, Industrial Waste and Hazardous Waste) and Service (Collection and Disposable): Global Opportunity Analysis and Industry Forecast, 2023-2032". According to the report, the global waste management market was valued at $1,860,212.6 million in 2020, and is projected to reach $3,498,176.5 million by 2032, registering a CAGR of 5.5% from 2023 to 2032.
Request PDF Sample Copy @ https://www.alliedmarketresearch.com/request-sample/423
The…
3D Concrete Printing Market to Surge from $371.7 Million in 2021 to $1,256.5 Bil …
According to a new report published by Allied Market Research, titled "3D Concrete Printing Market," The 3D concrete printing market size was valued at $371.70 million in 2021, and is estimated to reach $1,256.5 billion by 2031, growing at a CAGR of 131.8% from 2022 to 2031. 3D concrete printing process involves construction of building structures and other infrastructures using concrete and atomized machines. Walls, roofs, and pillars can be…
Global Wafer Processing Equipment Market to Reach $14.4 Billion by 2031: Allied …
According to the report published by Allied Market Research, the global wafer processing equipment market generated $8.5 billion in 2021, and is projected to reach $14.4 billion by 2031, growing at a CAGR of 5.3% from 2022 to 2031. The report offers a detailed analysis of the top winning strategies, evolving market trends, market size and estimations, value chain, key investment pockets, drivers & opportunities, competitive landscape, and regional landscape.…
More Releases for Malaria
Industry Dynamics of Cerebral Malaria Therapeutics
Global Cerebral Malaria Therapeutics Market: Overview
Cerebral malaria, a severe neuropathological complication, primarily caused by Plasmodium falciparum. The infectious disease has become prevalent in tropical and sub-tropical countries. The cerebral malaria therapeutics market has evolved on the back of increased understanding of pathogenesis of the neurological syndrome. A growing array of biomarkers and tool in recent years have helped underpin the growing revenue potential in the market, giving rise to numerous…
Malaria Vaccines – Paving the Way for a Malaria-free World
Recent Study on “Malaria Vaccines Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis and Forecast, 2018-2026” Added to Coherent Market Insights Reports Database.
Malaria Vaccines Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Malaria Vaccines market research report is a professional…
Malaria Disease Drug Pipeline Analysis
“Malaria Disease Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Malaria. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each drug…
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has…
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has…
Malaria Diagnostics Market : Future Growth Potential Of The Malaria Diagnostic & …
Malaria is caused by the Plasmodium parasite, which is transmitted by the female Anopheles mosquito. As per the WHO, there were around 203 mn cases of malaria worldwide in 2012, resulting in approximately 627,000 deaths. The diagnosis of malaria involves detection with the help of blood tests and microscopy. Early and accurate diagnosis of malaria is vital for the rapid recovery of the patient and this has raised investments in…
